Stocks · Health care · Pharmaceutical Preparations

Xencor Inc

XNCR Clue Score24
United States Fiscal year ends December CIK 0001326732 Results filed 4 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Bassil I Dahiyat
19 Dec 2025
President & CEO
Sold after exercise
114,377
$15.71
$1.80M
John R Desjarlais
19 Dec 2025
Sr. Vice President & CSO
Sold after exercise
73,367
$15.72
$1.15M

What was left out

Form 4 filings counted 25
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 5
Sales straight out of an exercise 2
Sales at will 11
Transactions with no price 0
Shares from compensation/vesting 452,753
History held since 6 Dec 2013